Methyl 2-Oxoindoline-6-Carboxylate CAS 14192-26-8 Purità > 99.0% (HPLC) Fabbrika Intermedja ta' Nintedanib Esylate
Shanghai Ruifu Chemical Co., Ltd hija l-manifattur u l-fornitur ewlieni ta 'Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) bi produzzjoni kummerċjali ta' kwalità għolja.
Isem Kimiku | Metil 2-Oxoindoline-6-Carboxylate |
Sinonimi | 2-Oxoindoline-6-Carboxylic Acid Methyl Ester;Methyl Oxindole-6-Carboxylate |
Numru CAS | 14192-26-8 |
Numru tal-KAT | RF-PI1524 |
Status tal-istokk | Fil-Ħażna, Skala ta' Produzzjoni Sa Tunnellati |
Formula Molekulari | C10H9NO3 |
Piż Molekulari | 191.19 |
Punt tat-tidwib | 184.0 ~ 190.0 ℃ |
Brand | Ruifu Kimika |
Oġġett | Speċifikazzjonijiet |
Dehra | Trab Isfar ċar għal Kannella |
Spettru 1H NMR | Konsistenti mal-Istruttura |
Purità / Metodu ta 'Analiżi | >99.0% (HPLC) |
Telf fuq Tnixxif | <1.00% |
Impuritajiet Totali | <1.00% |
Standard tat-Test | Standard tal-Intrapriża |
Użu | Intermedju ta 'Nintedanib Esylate (CAS: 656247-18-6) |
Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) Rotta Sintetika
Pakkett: Flixkun, borża tal-fojl tal-aluminju, 25kg/Drum tal-Kartun, jew skont il-ħtieġa tal-klijent.
Kundizzjoni tal-Ħżin:Aħżen f'kontenituri ssiġillati f'post frisk u niexef;Ipproteġi mid-dawl u l-umdità.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) huwa intermedju użat biex jipprepara Nintedanib Esylate (CAS: 656247-18-6).Nintedanib Esylate huwa inibitur orali qawwi ta' angiokinase triplu żviluppat minn Boehringer Ingelheim li jimmira mogħdijiet proanġjoġeniċi u pro-fibrotiċi medjati mir-riċettur tal-fattur tat-tkabbir endoteljali vaskulari, riċettur tal-fattur tat-tkabbir tal-fibroblast u familji tar-riċetturi tal-fattur tat-tkabbir derivati mill-plejtlets, kif ukoll Src u Flt-3 kinażi.Nintedanib Esylate ġie approvat għat-trattament tal-fibrożi pulmonari idjopatika (IPF), kundizzjoni li fiha l-pulmuni jsiru ċikatriċi progressivament maż-żmien, mill-FDA tal-Istati Uniti f'Ottubru 2014 u mill-EMA f'Jannar 2015. L-FDA tat nintedanib esylate fast-track. , reviżjoni prijoritarja, prodott orfni, u denominazzjonijiet innovattivi.Ġie approvat ukoll mill-EMA f'Novembru 2014 għat-trattament ta' kanċer tal-pulmun mhux taċ-ċelluli żgħar flimkien ma' docetaxel wara kimoterapija tal-ewwel linja.
-
Methyl 2-Oxoindoline-6-Carboxylate CAS 14192-26...
-
(S)-(-)-Indoline-2-Carboxylic Acid CAS 79815-20...
-
(±)-Indoline-2-Carboxylic Acid CAS 78348-24-0 P...
-
1-Amino-2-Methylindoline Hydrochloride CAS 1027...
-
2-Methylindoline CAS 6872-06-6 Purità >99.5% (G...
-
5-Bromo-7-Nitroindoline CAS 80166-90-1 Purità >...
-
Indoline CAS 496-15-1 Purità > 99.0% (GC) Fattur...
-
1-Boc-Indole CAS 75400-67-8 Purità > 96.0% (HPLC...
-
1-Methylindole CAS 603-76-9 Purità > 98.0% (GC) ...
-
1-Methylindole-3-Carboxaldehyde CAS 138423-98-0...
-
1-Methylindole-3-Carboxaldehyde CAS 19012-03-4...
-
1-Methylindole-3-Carboxylic Acid CAS 32387-21-6...
-
(N-Boc-5-bromo-2-indolil) Aċidu Boroniku CAS 47510...
-
1-(Phenylsulfonyl)indole CAS 40899-71-6 Purità...
-
1H-Indol-3-Carbohydrazide CAS 15317-58-5 Purit...
-
1H-Indole-7-Carboxamide CAS 1670-89-9 Purità >9...